 | • レポートコード：MRC2-11QY10760 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はトピラマートのグローバル市場について調査・分析したレポートです。種類別（0.98、0.99、その他）市場規模、用途別（抗けいれん薬、抗けいれん薬、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別トピラマートの競争状況、市場シェア ・世界のトピラマート市場：種類別市場規模 2015年-2020年（0.98、0.99、その他） ・世界のトピラマート市場：種類別市場規模予測 2021年-2026年（0.98、0.99、その他） ・世界のトピラマート市場：用途別市場規模 2015年-2020年（抗けいれん薬、抗けいれん薬、その他） ・世界のトピラマート市場：用途別市場規模予測 2021年-2026年（抗けいれん薬、抗けいれん薬、その他） ・北米のトピラマート市場分析：米国、カナダ ・ヨーロッパのトピラマート市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのトピラマート市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のトピラマート市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのトピラマート市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Chemwerth Inc.、Helm New York、Levachem、Depew Fine Chemical、Huadong Medicine (Xi'an) Bodyguard Pharmaceutical、Shaanxi Dasheng Pharmaceutical、Biddle Sawyer Corp.、Ortho-McNeil Pharmaceutical、Hangzhou Pharma & Chem、Chuming Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Topiramate Market
The global Topiramate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Topiramate Scope and Market Size
Topiramate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Topiramate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Topiramate market is segmented into
0.98
0.99
Others
Segment by Application, the Topiramate market is segmented into
Anticonvulsant
Antimigraine
Others
Regional and Country-level Analysis
The Topiramate market is analysed and market size information is provided by regions (countries).
The key regions covered in the Topiramate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Topiramate Market Share Analysis
Topiramate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Topiramate business, the date to enter into the Topiramate market, Topiramate product introduction, recent developments, etc.
The major vendors covered:
Chemwerth Inc.
Helm New York
Levachem
Depew Fine Chemical
Huadong Medicine (Xi’an) Bodyguard Pharmaceutical
Shaanxi Dasheng Pharmaceutical
Biddle Sawyer Corp.
Ortho-McNeil Pharmaceutical
Hangzhou Pharma & Chem
Chuming Pharmaceutical
1 Study Coverage
1.1 Topiramate Product Introduction
1.2 Market Segments
1.3 Key Topiramate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Topiramate Market Size Growth Rate by Type
1.4.2 0.98
1.4.3 0.99
1.4.4 Others
1.5 Market by Application
1.5.1 Global Topiramate Market Size Growth Rate by Application
1.5.2 Anticonvulsant
1.5.3 Antimigraine
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Topiramate Market Size, Estimates and Forecasts
2.1.1 Global Topiramate Revenue 2015-2026
2.1.2 Global Topiramate Sales 2015-2026
2.2 Global Topiramate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Topiramate Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Topiramate Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Topiramate Competitor Landscape by Players
3.1 Topiramate Sales by Manufacturers
3.1.1 Topiramate Sales by Manufacturers (2015-2020)
3.1.2 Topiramate Sales Market Share by Manufacturers (2015-2020)
3.2 Topiramate Revenue by Manufacturers
3.2.1 Topiramate Revenue by Manufacturers (2015-2020)
3.2.2 Topiramate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Topiramate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Topiramate Revenue in 2019
3.2.5 Global Topiramate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Topiramate Price by Manufacturers
3.4 Topiramate Manufacturing Base Distribution, Product Types
3.4.1 Topiramate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Topiramate Product Type
3.4.3 Date of International Manufacturers Enter into Topiramate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Topiramate Market Size by Type (2015-2020)
4.1.1 Global Topiramate Sales by Type (2015-2020)
4.1.2 Global Topiramate Revenue by Type (2015-2020)
4.1.3 Topiramate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Topiramate Market Size Forecast by Type (2021-2026)
4.2.1 Global Topiramate Sales Forecast by Type (2021-2026)
4.2.2 Global Topiramate Revenue Forecast by Type (2021-2026)
4.2.3 Topiramate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Topiramate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Topiramate Market Size by Application (2015-2020)
5.1.1 Global Topiramate Sales by Application (2015-2020)
5.1.2 Global Topiramate Revenue by Application (2015-2020)
5.1.3 Topiramate Price by Application (2015-2020)
5.2 Topiramate Market Size Forecast by Application (2021-2026)
5.2.1 Global Topiramate Sales Forecast by Application (2021-2026)
5.2.2 Global Topiramate Revenue Forecast by Application (2021-2026)
5.2.3 Global Topiramate Price Forecast by Application (2021-2026)
6 North America
6.1 North America Topiramate by Country
6.1.1 North America Topiramate Sales by Country
6.1.2 North America Topiramate Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Topiramate Market Facts & Figures by Type
6.3 North America Topiramate Market Facts & Figures by Application
7 Europe
7.1 Europe Topiramate by Country
7.1.1 Europe Topiramate Sales by Country
7.1.2 Europe Topiramate Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Topiramate Market Facts & Figures by Type
7.3 Europe Topiramate Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Topiramate by Region
8.1.1 Asia Pacific Topiramate Sales by Region
8.1.2 Asia Pacific Topiramate Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Topiramate Market Facts & Figures by Type
8.3 Asia Pacific Topiramate Market Facts & Figures by Application
9 Latin America
9.1 Latin America Topiramate by Country
9.1.1 Latin America Topiramate Sales by Country
9.1.2 Latin America Topiramate Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Topiramate Market Facts & Figures by Type
9.3 Central & South America Topiramate Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Topiramate by Country
10.1.1 Middle East and Africa Topiramate Sales by Country
10.1.2 Middle East and Africa Topiramate Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Topiramate Market Facts & Figures by Type
10.3 Middle East and Africa Topiramate Market Facts & Figures by Application
11 Company Profiles
11.1 Chemwerth Inc.
11.1.1 Chemwerth Inc. Corporation Information
11.1.2 Chemwerth Inc. Description and Business Overview
11.1.3 Chemwerth Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Chemwerth Inc. Topiramate Products Offered
11.1.5 Chemwerth Inc. Related Developments
11.2 Helm New York
11.2.1 Helm New York Corporation Information
11.2.2 Helm New York Description and Business Overview
11.2.3 Helm New York Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helm New York Topiramate Products Offered
11.2.5 Helm New York Related Developments
11.3 Levachem
11.3.1 Levachem Corporation Information
11.3.2 Levachem Description and Business Overview
11.3.3 Levachem Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Levachem Topiramate Products Offered
11.3.5 Levachem Related Developments
11.4 Depew Fine Chemical
11.4.1 Depew Fine Chemical Corporation Information
11.4.2 Depew Fine Chemical Description and Business Overview
11.4.3 Depew Fine Chemical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Depew Fine Chemical Topiramate Products Offered
11.4.5 Depew Fine Chemical Related Developments
11.5 Huadong Medicine (Xi’an) Bodyguard Pharmaceutical
11.5.1 Huadong Medicine (Xi’an) Bodyguard Pharmaceutical Corporation Information
11.5.2 Huadong Medicine (Xi’an) Bodyguard Pharmaceutical Description and Business Overview
11.5.3 Huadong Medicine (Xi’an) Bodyguard Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Huadong Medicine (Xi’an) Bodyguard Pharmaceutical Topiramate Products Offered
11.5.5 Huadong Medicine (Xi’an) Bodyguard Pharmaceutical Related Developments
11.6 Shaanxi Dasheng Pharmaceutical
11.6.1 Shaanxi Dasheng Pharmaceutical Corporation Information
11.6.2 Shaanxi Dasheng Pharmaceutical Description and Business Overview
11.6.3 Shaanxi Dasheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Shaanxi Dasheng Pharmaceutical Topiramate Products Offered
11.6.5 Shaanxi Dasheng Pharmaceutical Related Developments
11.7 Biddle Sawyer Corp.
11.7.1 Biddle Sawyer Corp. Corporation Information
11.7.2 Biddle Sawyer Corp. Description and Business Overview
11.7.3 Biddle Sawyer Corp. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biddle Sawyer Corp. Topiramate Products Offered
11.7.5 Biddle Sawyer Corp. Related Developments
11.8 Ortho-McNeil Pharmaceutical
11.8.1 Ortho-McNeil Pharmaceutical Corporation Information
11.8.2 Ortho-McNeil Pharmaceutical Description and Business Overview
11.8.3 Ortho-McNeil Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ortho-McNeil Pharmaceutical Topiramate Products Offered
11.8.5 Ortho-McNeil Pharmaceutical Related Developments
11.9 Hangzhou Pharma & Chem
11.9.1 Hangzhou Pharma & Chem Corporation Information
11.9.2 Hangzhou Pharma & Chem Description and Business Overview
11.9.3 Hangzhou Pharma & Chem Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hangzhou Pharma & Chem Topiramate Products Offered
11.9.5 Hangzhou Pharma & Chem Related Developments
11.10 Chuming Pharmaceutical
11.10.1 Chuming Pharmaceutical Corporation Information
11.10.2 Chuming Pharmaceutical Description and Business Overview
11.10.3 Chuming Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chuming Pharmaceutical Topiramate Products Offered
11.10.5 Chuming Pharmaceutical Related Developments
11.1 Chemwerth Inc.
11.1.1 Chemwerth Inc. Corporation Information
11.1.2 Chemwerth Inc. Description and Business Overview
11.1.3 Chemwerth Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Chemwerth Inc. Topiramate Products Offered
11.1.5 Chemwerth Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Topiramate Market Estimates and Projections by Region
12.1.1 Global Topiramate Sales Forecast by Regions 2021-2026
12.1.2 Global Topiramate Revenue Forecast by Regions 2021-2026
12.2 North America Topiramate Market Size Forecast (2021-2026)
12.2.1 North America: Topiramate Sales Forecast (2021-2026)
12.2.2 North America: Topiramate Revenue Forecast (2021-2026)
12.2.3 North America: Topiramate Market Size Forecast by Country (2021-2026)
12.3 Europe Topiramate Market Size Forecast (2021-2026)
12.3.1 Europe: Topiramate Sales Forecast (2021-2026)
12.3.2 Europe: Topiramate Revenue Forecast (2021-2026)
12.3.3 Europe: Topiramate Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Topiramate Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Topiramate Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Topiramate Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Topiramate Market Size Forecast by Region (2021-2026)
12.5 Latin America Topiramate Market Size Forecast (2021-2026)
12.5.1 Latin America: Topiramate Sales Forecast (2021-2026)
12.5.2 Latin America: Topiramate Revenue Forecast (2021-2026)
12.5.3 Latin America: Topiramate Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Topiramate Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Topiramate Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Topiramate Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Topiramate Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Topiramate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Topiramate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Topiramate Market Segments
Table 2. Ranking of Global Top Topiramate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Topiramate Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of 0.98
Table 5. Major Manufacturers of 0.99
Table 6. Major Manufacturers of Others
Table 7. Global Topiramate Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Topiramate Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Topiramate Sales by Regions 2015-2020 (K MT)
Table 10. Global Topiramate Sales Market Share by Regions (2015-2020)
Table 11. Global Topiramate Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Topiramate Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Topiramate Sales Share by Manufacturers (2015-2020)
Table 14. Global Topiramate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Topiramate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Topiramate as of 2019)
Table 16. Topiramate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Topiramate Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Topiramate Price (2015-2020) (USD/MT)
Table 19. Topiramate Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Topiramate Product Type
Table 21. Date of International Manufacturers Enter into Topiramate Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Topiramate Sales by Type (2015-2020) (K MT)
Table 24. Global Topiramate Sales Share by Type (2015-2020)
Table 25. Global Topiramate Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Topiramate Revenue Share by Type (2015-2020)
Table 27. Topiramate Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Topiramate Sales by Application (2015-2020) (K MT)
Table 29. Global Topiramate Sales Share by Application (2015-2020)
Table 30. North America Topiramate Sales by Country (2015-2020) (K MT)
Table 31. North America Topiramate Sales Market Share by Country (2015-2020)
Table 32. North America Topiramate Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Topiramate Revenue Market Share by Country (2015-2020)
Table 34. North America Topiramate Sales by Type (2015-2020) (K MT)
Table 35. North America Topiramate Sales Market Share by Type (2015-2020)
Table 36. North America Topiramate Sales by Application (2015-2020) (K MT)
Table 37. North America Topiramate Sales Market Share by Application (2015-2020)
Table 38. Europe Topiramate Sales by Country (2015-2020) (K MT)
Table 39. Europe Topiramate Sales Market Share by Country (2015-2020)
Table 40. Europe Topiramate Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Topiramate Revenue Market Share by Country (2015-2020)
Table 42. Europe Topiramate Sales by Type (2015-2020) (K MT)
Table 43. Europe Topiramate Sales Market Share by Type (2015-2020)
Table 44. Europe Topiramate Sales by Application (2015-2020) (K MT)
Table 45. Europe Topiramate Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Topiramate Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Topiramate Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Topiramate Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Topiramate Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Topiramate Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Topiramate Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Topiramate Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Topiramate Sales Market Share by Application (2015-2020)
Table 54. Latin America Topiramate Sales by Country (2015-2020) (K MT)
Table 55. Latin America Topiramate Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Topiramate Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Topiramate Revenue Market Share by Country (2015-2020)
Table 58. Latin America Topiramate Sales by Type (2015-2020) (K MT)
Table 59. Latin America Topiramate Sales Market Share by Type (2015-2020)
Table 60. Latin America Topiramate Sales by Application (2015-2020) (K MT)
Table 61. Latin America Topiramate Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Topiramate Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Topiramate Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Topiramate Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Topiramate Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Topiramate Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Topiramate Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Topiramate Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Topiramate Sales Market Share by Application (2015-2020)
Table 70. Chemwerth Inc. Corporation Information
Table 71. Chemwerth Inc. Description and Major Businesses
Table 72. Chemwerth Inc. Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Chemwerth Inc. Product
Table 74. Chemwerth Inc. Recent Development
Table 75. Helm New York Corporation Information
Table 76. Helm New York Description and Major Businesses
Table 77. Helm New York Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Helm New York Product
Table 79. Helm New York Recent Development
Table 80. Levachem Corporation Information
Table 81. Levachem Description and Major Businesses
Table 82. Levachem Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Levachem Product
Table 84. Levachem Recent Development
Table 85. Depew Fine Chemical Corporation Information
Table 86. Depew Fine Chemical Description and Major Businesses
Table 87. Depew Fine Chemical Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Depew Fine Chemical Product
Table 89. Depew Fine Chemical Recent Development
Table 90. Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Corporation Information
Table 91. Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Description and Major Businesses
Table 92. Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Product
Table 94. Huadong Medicine (Xi'an) Bodyguard Pharmaceutical Recent Development
Table 95. Shaanxi Dasheng Pharmaceutical Corporation Information
Table 96. Shaanxi Dasheng Pharmaceutical Description and Major Businesses
Table 97. Shaanxi Dasheng Pharmaceutical Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Shaanxi Dasheng Pharmaceutical Product
Table 99. Shaanxi Dasheng Pharmaceutical Recent Development
Table 100. Biddle Sawyer Corp. Corporation Information
Table 101. Biddle Sawyer Corp. Description and Major Businesses
Table 102. Biddle Sawyer Corp. Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Biddle Sawyer Corp. Product
Table 104. Biddle Sawyer Corp. Recent Development
Table 105. Ortho-McNeil Pharmaceutical Corporation Information
Table 106. Ortho-McNeil Pharmaceutical Description and Major Businesses
Table 107. Ortho-McNeil Pharmaceutical Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Ortho-McNeil Pharmaceutical Product
Table 109. Ortho-McNeil Pharmaceutical Recent Development
Table 110. Hangzhou Pharma & Chem Corporation Information
Table 111. Hangzhou Pharma & Chem Description and Major Businesses
Table 112. Hangzhou Pharma & Chem Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Hangzhou Pharma & Chem Product
Table 114. Hangzhou Pharma & Chem Recent Development
Table 115. Chuming Pharmaceutical Corporation Information
Table 116. Chuming Pharmaceutical Description and Major Businesses
Table 117. Chuming Pharmaceutical Topiramate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Chuming Pharmaceutical Product
Table 119. Chuming Pharmaceutical Recent Development
Table 120. Global Topiramate Sales Forecast by Regions (2021-2026) (K MT)
Table 121. Global Topiramate Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Topiramate Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Topiramate Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Topiramate Sales Forecast by Country (2021-2026) (K MT)
Table 125. North America: Topiramate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Topiramate Sales Forecast by Country (2021-2026) (K MT)
Table 127. Europe: Topiramate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Topiramate Sales Forecast by Region (2021-2026) (K MT)
Table 129. Asia Pacific: Topiramate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Topiramate Sales Forecast by Country (2021-2026) (K MT)
Table 131. Latin America: Topiramate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Topiramate Sales Forecast by Country (2021-2026) (K MT)
Table 133. Middle East and Africa: Topiramate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Topiramate Players
Table 138. Topiramate Customers List
Table 139. Topiramate Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Topiramate Product Picture
Figure 2. Global Topiramate Sales Market Share by Type in 2020 & 2026
Figure 3. 0.98 Product Picture
Figure 4. 0.99 Product Picture
Figure 5. Others Product Picture
Figure 6. Global Topiramate Sales Market Share by Application in 2020 & 2026
Figure 7. Anticonvulsant
Figure 8. Antimigraine
Figure 9. Others
Figure 10. Topiramate Report Years Considered
Figure 11. Global Topiramate Market Size 2015-2026 (US$ Million)
Figure 12. Global Topiramate Sales 2015-2026 (K MT)
Figure 13. Global Topiramate Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Topiramate Sales Market Share by Region (2015-2020)
Figure 15. Global Topiramate Sales Market Share by Region in 2019
Figure 16. Global Topiramate Revenue Market Share by Region (2015-2020)
Figure 17. Global Topiramate Revenue Market Share by Region in 2019
Figure 18. Global Topiramate Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Topiramate Revenue in 2019
Figure 20. Topiramate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Topiramate Sales Market Share by Type (2015-2020)
Figure 22. Global Topiramate Sales Market Share by Type in 2019
Figure 23. Global Topiramate Revenue Market Share by Type (2015-2020)
Figure 24. Global Topiramate Revenue Market Share by Type in 2019
Figure 25. Global Topiramate Market Share by Price Range (2015-2020)
Figure 26. Global Topiramate Sales Market Share by Application (2015-2020)
Figure 27. Global Topiramate Sales Market Share by Application in 2019
Figure 28. Global Topiramate Revenue Market Share by Application (2015-2020)
Figure 29. Global Topiramate Revenue Market Share by Application in 2019
Figure 30. North America Topiramate Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Topiramate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Topiramate Sales Market Share by Country in 2019
Figure 33. North America Topiramate Revenue Market Share by Country in 2019
Figure 34. U.S. Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Topiramate Market Share by Type in 2019
Figure 39. North America Topiramate Market Share by Application in 2019
Figure 40. Europe Topiramate Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Topiramate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Topiramate Sales Market Share by Country in 2019
Figure 43. Europe Topiramate Revenue Market Share by Country in 2019
Figure 44. Germany Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Topiramate Market Share by Type in 2019
Figure 55. Europe Topiramate Market Share by Application in 2019
Figure 56. Asia Pacific Topiramate Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Topiramate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Topiramate Sales Market Share by Region in 2019
Figure 59. Asia Pacific Topiramate Revenue Market Share by Region in 2019
Figure 60. China Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Topiramate Market Share by Type in 2019
Figure 83. Asia Pacific Topiramate Market Share by Application in 2019
Figure 84. Latin America Topiramate Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Topiramate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Topiramate Sales Market Share by Country in 2019
Figure 87. Latin America Topiramate Revenue Market Share by Country in 2019
Figure 88. Mexico Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Topiramate Market Share by Type in 2019
Figure 95. Latin America Topiramate Market Share by Application in 2019
Figure 96. Middle East and Africa Topiramate Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Topiramate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Topiramate Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Topiramate Revenue Market Share by Country in 2019
Figure 100. Turkey Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Topiramate Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Topiramate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Topiramate Market Share by Type in 2019
Figure 107. Middle East and Africa Topiramate Market Share by Application in 2019
Figure 108. North America Topiramate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Topiramate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Topiramate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Topiramate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Topiramate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Topiramate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Topiramate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Topiramate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Topiramate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Topiramate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
特発性頭蓋内圧亢進症治療薬の世界市場（～2026年） A drug used to treat idiopathic intracranial hypertension. Market Analysis and Insights: Global Idiopathic Intracranial Hypertension Therapeutics Market The global Idiopathic Intracranial Hypertension Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…- 特発性頭蓋内圧亢進症治療の世界市場（～2026年） Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…
- 抗肥満処方の世界市場（～2026年） Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory …
- レイノー現象管理の世界市場（～2026年） Raynaud's phenomenon is a medical condition in which spasm of arteries cause episodes of reduced blood flow. North America dominates the global market of Raynaud’s phenomenon management owing to the presence of reimbursement scenario and skilled professionals. Market Analysis and Insights: Global Ra…
- 発作治療の世界市場（～2026年） An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. Increasing prevalence of neurological disorders is expected to be the dominant factor driving the global seize treatment market over the forecast period. Market Ana…